Quarterly report pursuant to Section 13 or 15(d)

Stock Options, Restricted Stock Units And Warrants (Tables)

v3.22.2.2
Stock Options, Restricted Stock Units And Warrants (Tables)
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of stock based compensation
    Three months ended
June 30,
    Six months ended
June 30,
 
    2022     2021     2022     2021  
                         
Research and development expenses   $ 445     $ 32     $ 500     $ 614  
Selling, general and administrative expenses     1,003       2,551       2,031       5,435  
Total stock-based compensation   $ 1,448     $ 2,583     $ 2,531     $ 6,049  

 

Schedule of estimation of fair value of stock-based compensation
    Three months ended
June 30,
  Six months ended
June 30,
    2022   2021   2022   2021
Dividend yield   0%   0%   0%   0%
Expected price volatility   91.7%   50.0%   91.7%   50.0%
Risk free interest rate   3.25%   0.35% - 0.90%   3.25%   0.22-0.94%
Expected term   5.0-7.0 years   3.0-5.0 years   5.0-7.0 years   2.5-7.0 years

 

Schedule of stock options
    Shares Underlying
Options
    Weighted Average
Exercise Price
    Weighted Average
Remaining
Contractual
 Term (Years)
    Aggregate Intrinsic
Value
 
Outstanding at December 31, 2021     11,135,432     $ 2.85       7.6     $ 13,031  
Granted     65,000     $ 1.12       9.9          
Canceled     (652,776 )   $ 3.50      
-
         
Forfeited     (1,476,670 )   $ 2.60      
-
         
Outstanding at June 30, 2022     9,070,986     $ 2.83       6.9     $ 510  
                                 
Exercisable at June 30, 2022     8,395,464     $ 2.78       6.7     $ 510  

 

Schedule of restricted stock unit
    Number of Shares     Weighted Average
Grant-Date
Fair Value
 
Unvested at December 31, 2021     1,939,683     $ 3.40  
Granted     138,850     $ 1.48  
Vested     (1,561,904 )   $ 3.88  
Unvested at June 30, 2022     516,629     $ 4.28  

 

Schedule of warrant activity
    Shares
Underlying
Warrants
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term (Years)
    Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2021     4,525,177     $ 2.65       4.0     $ 7,088  
Issued     200,000     $ 2.00                  
Outstanding at June 30, 2022     4,725,177     $ 2.62       3.5     $ 611  
                                 
Exercisable at June 30, 2022     1,175,913     $ 0.33       3.6     $ 611  

 

Schedule of estimated the fair value of the warrants
    Six months ended
June 30,
 
    2022     2021  
             
Expected price volatility     103.0 %     50.0 %
Risk free interest rate     2.2 %     0.4 %
Expected term (years)     5.0       5.0